Gene therapy targeting INa represents a promising future strategy for the long-term treatment of life-threatening ventricular arrhythmias.
Answers are grounded in this paper and cite their sources.
Gene therapy for ventricular arrhythmias remains investigational; leaves open clinical translation pending rigorous human trials.
Future perspectives in treating cardiac arrhythmias. Gene therapy is emerging as a promising strategy for treating ventricular arrhythmias, aiming to restore normal sinus rhythms. Current approaches in gene therapy are focused on modifying the underlying electrical disturbances that cause these arrhythmias. Moving beyond proof-of-concept, gene therapy has the potential to provide long-term solutions for patients with life-threatening arrhythmias, offering a hopeful outlook for the future.
No takes yet. Share an insight, caveat, or question.
Patrick Lugenbiel (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: